+152.4%
MRNA vs ROIV
+337.3%
-184.8%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | ROIV | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.3% | +0.6% | +0.7% | +0.9% |
| 7D | -13.8% | -2.6% | -11.3% | -12.5% |
| 30D | -17.7% | +11.6% | -29.2% | -22.4% |
| 3M | +14.3% | +4.2% | +10.1% | +9.8% |
| 6M | +336.0% | +38.1% | +297.9% | +249.9% |
| YTD | +575.9% | +79.5% | +496.4% | +361.0% |
| 1Y | +724.4% | +91.5% | +632.8% | +436.6% |
| All | +152.4% | +337.3% | -184.8% | +2.9% |
Cumulative growth
Daily Returns
Daily percentage return beside ROIV.
Daily Out/Under-Performance
Portfolio return minus ROIV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ROIV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded ROIV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling